Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Lung Cancer

Free Subscription Articles published in J Surg Oncol Retrieve available abstracts of 33 articles: HTML format Text format

Single Articles

June 2018
1. IMANISHI N, Hirai A, Yoneda K, Shimajiri S, et al
   Programmed death-ligand 1 (PD-L1) expression in pleomorphic carcinoma of the lung.
   J Surg Oncol. 2018;117:1563-1569.
   PubMed     Text format     Abstract available
   
   
   May 2018
2. SAMBRI A, Bianchi G, Cevolani L, Donati D, et al
   Can radical margins improve prognosis in primary and localized epithelioid sarcoma of the extremities?
   J Surg Oncol. 2018;117:1204-1210.
   PubMed     Text format     Abstract available
   
   
   April 2018
3. MIYAMOTO E, Chen-Yoshikawa TF, Ueshima C, Yoshizawa A, et al
   Transition of the programmed death 1 pathway from the primary colorectal cancer to its corresponding pulmonary metastasis.
   J Surg Oncol. 2018 Apr 17. doi: 10.1002/jso.25045.
   PubMed     Text format     Abstract available
   
   
   
4. KAAKI S, Kidane B, Srinathan S, Tan L, et al
   Is tissue still the issue? Lobectomy for suspicious lung nodules without confirmation of malignancy.
   J Surg Oncol. 2018;117:977-984.
   PubMed     Text format     Abstract available
   
   
   March 2018
5. COLLAUD S, Provost B, Besse B, Fabre D, et al
   Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?
   J Surg Oncol. 2018 Mar 24. doi: 10.1002/jso.25042.
   PubMed     Text format     Abstract available
   
   
   
6. SON BY, Cho S, Yum SW, Kim K, et al
   The maximum standardized uptake value of preoperative positron emission tomography/computed tomography in lung adenocarcinoma with a ground-glass opacity component of less than 30 mm.
   J Surg Oncol. 2018;117:451-456.
   PubMed     Text format     Abstract available
   
   
   
7. FISHER SB, Rafeeq S, Hess K, Grotz TE, et al
   Elevated brain natriuretic peptide (BNP) is an early marker for patients at risk for complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC).
   J Surg Oncol. 2018;117:685-691.
   PubMed     Text format     Abstract available
   
   
   February 2018
8. YU WS, Lee CY, Park SY, Suh JW, et al
   Prognostic factors for resected non-small cell lung cancer in patients with type 2 diabetes mellitus.
   J Surg Oncol. 2018 Feb 6. doi: 10.1002/jso.24989.
   PubMed     Text format     Abstract available
   
   
   
9. VODICKA J, Mukensnabl P, Vejvodova S, Spidlen V, et al
   A more sensitive detection of micrometastases of NSCLC in lymph nodes using the one-step nucleic acid amplification (OSNA) method.
   J Surg Oncol. 2018;117:163-170.
   PubMed     Text format     Abstract available
   
   
   January 2018
10. QUERO-VALENZUELA F, Piedra-Fernandez I, Martinez-Ceres M, Romero-Palacios PJ, et al
    Predictors for 30-day readmission after pulmonary resection for lung cancer.
    J Surg Oncol. 2018 Jan 22. doi: 10.1002/jso.24973.
    PubMed     Text format     Abstract available
    
    
    December 2017
11. SMITHY JW, Rosen JE, Gao SJ, Kim AW, et al
    Postneoadjuvant adjuvant chemotherapy in resected N1 non-small cell lung cancer with residual nodal disease.
    J Surg Oncol. 2017;116:1193-1196.
    PubMed     Text format     Abstract available
    
    
    November 2017
12. KAPETANAKIS EI, Sidiropoulou T, Koumarianou A, Kostopanagiotou K, et al
    Delivering quality lung cancer care in crisis-wracked Greece.
    J Surg Oncol. 2017 Nov 22. doi: 10.1002/jso.24874.
    PubMed     Text format    
    
    
    
13. SHE Y, Zhao L, Dai C, Ren Y, et al
    Development and validation of a nomogram to estimate the pretest probability of cancer in Chinese patients with solid solitary pulmonary nodules: A multi-institutional study.
    J Surg Oncol. 2017;116:756-762.
    PubMed     Text format     Abstract available
    
    
    October 2017
14. APRILE V, Bertoglio P, Dini P, Palmiero G, et al
    Is left upper lobectomy always worthwhile for early stage lung cancer? A comparison between left upper lobectomy, trisegmentectomy, and lingulectomy.
    J Surg Oncol. 2017 Oct 19. doi: 10.1002/jso.24884.
    PubMed     Text format     Abstract available
    
    
    September 2017
15. MARULLI G, Rendina EA, Klepetko W, Perkmann R, et al
    Surgery for T4 lung cancer invading the thoracic aorta: Do we push the limits?
    J Surg Oncol. 2017 Sep 18. doi: 10.1002/jso.24784.
    PubMed     Text format     Abstract available
    
    
    August 2017
16. WASEDA R, Klikovits T, Hoda MA, Hoetzenecker K, et al
    Trimodality therapy for Pancoast tumors: T4 is not a contraindication to radical surgery.
    J Surg Oncol. 2017;116:227-235.
    PubMed     Text format     Abstract available
    
    
    June 2017
17. TAIOLI E, Liu B, Nicastri DG, Lieberman-Cribbin W, et al
    Personal and hospital factors associated with limited surgical resection for lung cancer, in-hospital mortality and complications in New York State.
    J Surg Oncol. 2017 Jun 1. doi: 10.1002/jso.24697.
    PubMed     Text format     Abstract available
    
    
    May 2017
18. YANG X, Sun F, Chen L, Shi M, et al
    Prognostic value of visceral pleural invasion in non-small cell lung cancer: A propensity score matching study based on the SEER registry.
    J Surg Oncol. 2017 May 22. doi: 10.1002/jso.24677.
    PubMed     Text format     Abstract available
    
    
    April 2017
19. MCINTYRE A, Ganti AK
    Lung cancer-A global perspective.
    J Surg Oncol. 2017 Apr 18. doi: 10.1002/jso.24532.
    PubMed     Text format     Abstract available
    
    
    February 2017
20. SPARBER-SAUER M, Seitz G, Kirsch S, Vokuhl C, et al
    The impact of local control in the treatment of type II/III pleuropulmonary blastoma. Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS).
    J Surg Oncol. 2017;115:164-172.
    PubMed     Text format     Abstract available
    
    
    December 2016
21. LEE S, Lee JG, Lee CY, Kim DJ, et al
    Pulmonary fissure development is a prognostic factor for patients with resected stage I lung adenocarcinoma.
    J Surg Oncol. 2016;114:848-852.
    PubMed     Text format     Abstract available
    
    
    November 2016
22. BI Y, Deng Y, Li S, Zhou X, et al
    Immunophenotypic and prognostic analysis of PAX8 and TTF-1 expressions in neuroendocrine carcinomas of thymic origin: A comparative study with their pulmonary counterparts.
    J Surg Oncol. 2016;114:697-702.
    PubMed     Text format     Abstract available
    
    
    October 2016
23. SCHWARTZ RM, Yip R, Flores RM, Olkin I, et al
    The impact of resection method and patient factors on quality of life among stage IA non-small cell lung cancer surgical patients.
    J Surg Oncol. 2016 Oct 28. doi: 10.1002/jso.24478.
    PubMed     Text format     Abstract available
    
    
    September 2016
24. JAKUBOWSKI CD, Vertosick EA, Untch BR, Sjoberg D, et al
    Complete metastasectomy for renal cell carcinoma: Comparison of five solid organ sites.
    J Surg Oncol. 2016;114:375-9.
    PubMed     Text format     Abstract available
    
    
    August 2016
25. SANTANA-RODRIGUEZ N, Martel E, Clavo B, Llontop P, et al
    Oncological resection of lung cancer invading the aortic arch In full thickness using a non-fenestrated endograft.
    J Surg Oncol. 2016 Aug 22. doi: 10.1002/jso.24359.
    PubMed     Text format     Abstract available
    
    
    
26. MASAI K, Sakurai H, Suzuki S, Asakura K, et al
    Clinicopathological features of colloid adenocarcinoma of the lung: A report of six cases.
    J Surg Oncol. 2016;114:211-5.
    PubMed     Text format     Abstract available
    
    
    June 2016
27. PASSOT G, Vaudoyer D, Villeneuve L, Kepenekian V, et al
    What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: A 25-year experience with 1,125 procedures.
    J Surg Oncol. 2016;113:796-803.
    PubMed     Text format     Abstract available
    
    
    
28. RICHARDSON K, Potter M, Damron TA
    Image intensive soft tissue sarcoma surveillance uncovers pathology earlier than patient complaints but with frequent initially indeterminate lesions.
    J Surg Oncol. 2016;113:818-22.
    PubMed     Text format     Abstract available
    
    
    April 2016
29. BAUMANN BC, Nagda SN, Kolker JD, Levin WP, et al
    Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection.
    J Surg Oncol. 2016 Apr 25. doi: 10.1002/jso.24268.
    PubMed     Text format     Abstract available
    
    
    
30. DAI C, Ren Y, Xie H, Jiang S, et al
    Clinical and radiological features of synchronous pure ground-glass nodules observed along with operable non-small cell lung cancer.
    J Surg Oncol. 2016 Apr 4. doi: 10.1002/jso.24235.
    PubMed     Text format     Abstract available
    
    
    January 2016
31. ANG C, Miura JT, Gamblin TC, He R, et al
    Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options.
    J Surg Oncol. 2016;113:55-61.
    PubMed     Text format     Abstract available
    
    
    December 2015
32. PREDINA JD, Keating J, Patel N, Nims S, et al
    Clinical implications of positive margins following non-small cell lung cancer surgery.
    J Surg Oncol. 2015 Dec 30. doi: 10.1002/jso.24130.
    PubMed     Text format     Abstract available
    
    
    November 2015
33. ZHANG X, Chen Q, Chen J, He C, et al
    Association of polymorphisms in translesion synthesis genes with prognosis of advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy.
    J Surg Oncol. 2015 Nov 26. doi: 10.1002/jso.24103.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: